Strategic Education Inc header image

Strategic Education Inc

STRA

Equity

ISIN US86272C1036 / Valor 42985312

NASDAQ (2024-11-21)
USD 96.66+1.19%

Strategic Education Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Strategic Education Inc (NASDAQ: STRA) is a company focused on providing educational programs and services to working adult students, aiming to enhance their career prospects and overall quality of life. The company offers a range of innovative solutions to support individuals in achieving economic mobility through education.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Growth

Strategic Education Inc. reported an 8.5% increase in revenue for the second quarter of 2024, reaching $312.3 million compared to $287.7 million for the same period in 2023. On a constant currency basis, revenue increased by 8.9% to $313.4 million.

Income from Operations

Income from operations for Strategic Education Inc. in the second quarter of 2024 was $41.9 million, or 13.4% of revenue, compared to $16.8 million, or 5.8% of revenue, for the same period in 2023. Adjusted income from operations was $43.9 million, up from $27.2 million in the previous year.

Net Income

Strategic Education Inc. reported a net income of $29.9 million for the second quarter of 2024, compared to $14.2 million for the same period in 2023. Adjusted net income was $32.3 million, up from $19.7 million in the previous year.

Dividends

Strategic Education Inc. declared a regular quarterly cash dividend of $0.60 per share of common stock. This dividend will be paid on September 16, 2024, to shareholders of record as of September 6, 2024.

Cash Flow and Capital Expenditures

For the first six months of 2024, Strategic Education Inc. reported cash provided by operations of $101.9 million, compared to $40.7 million for the same period in 2023. Capital expenditures for the first six months of 2024 were $19.9 million, up from $17.8 million in the previous year.

Summarized from source with an LLMView Source

Key figures

8.83%1Y
67.7%3Y
-29.7%5Y

Performance

33.3%1Y
33.4%3Y
40.6%5Y

Volatility

Market cap

2347 M

Market cap (USD)

Daily traded volume (Shares)

55,547

Daily traded volume (Shares)

1 day high/low

97.115 / 95.81

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.50%USD 597.49
CVS Health Corp
CVS Health Corp CVS Health Corp Valor: 548525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 57.10
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.23%USD 332.24
Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 390.14
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.66%USD 197.60
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%USD 25.04
Bio-Rad Laboratories Inc
Bio-Rad Laboratories Inc Bio-Rad Laboratories Inc Valor: 912793
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%USD 325.58
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd Valor: 758744
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.29%USD 17.08
Ono Yakuhin Kogyo KK
Ono Yakuhin Kogyo KK Ono Yakuhin Kogyo KK Valor: 763216
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.09%JPY 1,746.50
Novartis Inc
Novartis Inc Novartis Inc Valor: 567514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%USD 103.85